Showing results (51-60 of 154) with videos related to
Sort By:
Pageof 16
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|August 2, 2008
New visions for anaphylaxis: an iPAC summary and future trendsA Muraro, G Roberts, F Estelle R SimonsMethods in Molecular Biology (Clifton, N.J.)|June 10, 2019
Improved Methods for Quantifying Human Chemokine and Cytokine Biomarker Responses: Ultrasensitive ELISA and Meso Scale Electrochemiluminescence AssaysWilliam P Stefura, Caroline Graham, Larisa Lotoski, et al.The Journal of Nutrition|September 24, 2005
Antiatherogenic effects of dietary plant sterols are associated with inhibition of proinflammatory cytokine production in Apo E-KO miceBaher Nashed, Behzad Yeganeh, Kent T HayGlass, et al.Biopharmaceutics & Drug Disposition|July 13, 2002
Is epinephrine administration by sublingual tablet feasible for the first-aid treatment of anaphylaxis? A proof-of-concept studyXiaochen Gu, Keith J Simons, F Estelle R SimonsThe Journal of Allergy and Clinical Immunology|March 19, 2003
Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitisF Estelle R Simons, Bruce M Prenner, Albert Finn, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 1, 2012
Timing the transfer of responsibilities for anaphylaxis recognition and use of an epinephrine auto-injector from adults to children and teenagers: pediatric allergists' perspectiveElinor Simons, Scott H Sicherer, F Estelle R SimonsThe Journal of Allergy and Clinical Immunology|June 23, 2009
Anaphylaxis in the community: learning from the survivorsF Estelle R Simons, Sunday Clark, Carlos A CamargoThe Journal of Allergy and Clinical Immunology|October 10, 2002
Epinephrine dispensing patterns for an out-of-hospital population: a novel approach to studying the epidemiology of anaphylaxisF Estelle R Simons, Sandra Peterson, Charlyn D BlackCanadian Journal of Physiology and Pharmacology|September 8, 2007
Level of Toll-like receptor agonist exposure differentially determines chemokine production in humansYuriy Lissitsyn, Allan B Becker, Anita L Kozyrskyj, et al.The Cochrane Database of Systematic Reviews|March 19, 2010
Glucocorticoids for the treatment of anaphylaxisKaren Jui Lin Choo, F Estelle R Simons, Aziz SheikhPageof 16